Published in F1000 Med Rep on December 15, 2009
Causes, consequences, and treatment of osteoporosis in men. Drug Des Devel Ther (2013) 0.87
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med (2009) 13.57
A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med (2009) 11.20
A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med (2009) 10.06
Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med (2007) 9.83
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med (2009) 6.67
Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res (2009) 4.40
FRAX and its applications to clinical practice. Bone (2009) 3.32
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res (2009) 2.99
Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72
Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res (2009) 2.65
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ (2009) 2.64
Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom (2008) 2.21
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. Bone (2007) 1.94
Bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2009) 1.90
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86
Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results. Clin Breast Cancer (2009) 1.78
Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos Int (2005) 1.66
Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med (2009) 1.40
Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int (2009) 1.39
Bisphosphonate-associated adverse events. Hormones (Athens) (2009) 1.36
Burden of osteoporosis and fractures. Curr Osteoporos Rep (2003) 1.19
The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. Bone (2009) 1.15
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab (2008) 1.14
Postfracture care for older women: gaps between optimal care and actual care. Can Fam Physician (2008) 1.11
Effect of adherence on lifetime fractures in osteoporotic women treated with daily and weekly bisphosphonates. J Bone Miner Res (2009) 0.90
The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX. Osteoporos Int (2009) 0.86
The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis. Osteoporos Int (2009) 0.79
A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med (2009) 11.20
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2010) 6.00
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2013) 5.76
Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust (2012) 3.14
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab (2012) 2.87
Is high dose vitamin D harmful? Calcif Tissue Int (2012) 2.43
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev (2010) 2.38
Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis (2008) 2.10
Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care (2011) 1.67
Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Med J Aust (2002) 1.59
Association of cartilage defects with loss of knee cartilage in healthy, middle-age adults: a prospective study. Arthritis Rheum (2005) 1.49
Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab (2012) 1.45
Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf) (2012) 1.43
Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res (2011) 1.40
Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol (2010) 1.39
14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol (2010) 1.20
Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. PLoS One (2012) 1.14
Approach to the patient with secondary osteoporosis. Eur J Endocrinol (2010) 1.08
Routine screening for vitamin D deficiency in early pregnancy: past its due date? Med J Aust (2011) 1.08
Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency. J Bone Miner Res (2008) 1.05
Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT. J Clin Endocrinol Metab (2013) 1.04
Efficacy and safety of vertebroplasty for treatment of painful osteoporotic vertebral fractures: a randomised controlled trial [ACTRN012605000079640]. BMC Musculoskelet Disord (2008) 1.02
The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf) (2003) 0.99
Central abdominal fat and endogenous hormones during the menopausal transition. Fertil Steril (2003) 0.98
An atypical subtrochanteric femoral fracture from pycnodysostosis: a lesson from nature. J Bone Miner Res (2011) 0.96
Effects of a targeted multimodal exercise program incorporating high-speed power training on falls and fracture risk factors in older adults: a community-based randomized controlled trial. J Bone Miner Res (2014) 0.95
Effect of vitamin D supplementation on antibiotic use: a randomized controlled trial. Am J Clin Nutr (2013) 0.93
The effect of acute exercise on undercarboxylated osteocalcin and insulin sensitivity in obese men. J Bone Miner Res (2014) 0.93
Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adults. J Clin Endocrinol Metab (2014) 0.93
The relationship between body composition and knee cartilage volume in healthy, middle-aged subjects. Arthritis Rheum (2005) 0.92
Vitamin D deficiency and its role in muscle-bone interactions in the elderly. Curr Osteoporos Rep (2014) 0.91
Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. J Clin Endocrinol Metab (2015) 0.90
Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. J Clin Oncol (2009) 0.90
Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss. J Bone Miner Res (2015) 0.90
Osteo-cise: strong bones for life: protocol for a community-based randomised controlled trial of a multi-modal exercise and osteoporosis education program for older adults at risk of falls and fractures. BMC Musculoskelet Disord (2012) 0.89
Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting. Med J Aust (2010) 0.89
The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study. Osteoporos Int (2004) 0.88
Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults. Obesity (Silver Spring) (2014) 0.88
Declining incidence of osteoporotic hip fracture in Australia. Arch Osteoporos (2012) 0.88
Lack of sustained response to teriparatide in a patient with adult hypophosphatasia. J Clin Endocrinol Metab (2010) 0.86
Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis (2013) 0.86
Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg (2013) 0.86
25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol (2012) 0.86
Frequent walking, but not total physical activity, is associated with increased fracture incidence: a 5-year follow-up of an Australian population-based prospective study (AusDiab). J Bone Miner Res (2011) 0.85
Relationship between bone markers and knee cartilage volume in healthy men. J Rheumatol (2005) 0.84
Cord blood-derived macrophage-lineage cells rapidly stimulate osteoblastic maturation in mesenchymal stem cells in a glycoprotein-130 dependent manner. PLoS One (2013) 0.84
Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF). Clin Endocrinol (Oxf) (2008) 0.84
Predicting vitamin D deficiency in older Australian adults. Clin Endocrinol (Oxf) (2013) 0.83
Determinants of change in patella cartilage volume in healthy subjects. J Rheumatol (2006) 0.82
Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study. J Clin Endocrinol Metab (2015) 0.82
Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention. Med J Aust (2010) 0.82
Is excess calcium harmful to health? Nutrients (2010) 0.81
Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidence. Ther Adv Musculoskelet Dis (2013) 0.81
Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg (2008) 0.81
Two-year results of a randomized placebo-controlled trial of vertebroplasty for acute osteoporotic vertebral fractures. J Bone Miner Res (2014) 0.81
Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary. Clin Endocrinol (Oxf) (2008) 0.81
Vitamin d and physical activity status: associations with five-year changes in body composition and muscle function in community-dwelling older adults. J Clin Endocrinol Metab (2014) 0.81
What is the clinical and ethical importance of incidental abnormalities found by knee MRI? Arthritis Res Ther (2008) 0.80
A sample preparation protocol for 1H nuclear magnetic resonance studies of water-soluble metabolites in blood and urine. Anal Biochem (2009) 0.80
Megadose therapy for vitamin D deficiency. Med J Aust (2005) 0.80
Vitamin D Deficiency May Be Associated with a More Rapid Decline in CD4 Cell Count to <350 Cells/µL in Untreated HIV-Infected Adults. Curr HIV Res (2015) 0.80
Measurements of 25-hydroxyvitamin D concentrations in archived dried blood spots are reliable and accurately reflect those in plasma. J Clin Endocrinol Metab (2014) 0.79
Exercise as an intervention to improve metabolic outcomes after intrauterine growth restriction. Am J Physiol Endocrinol Metab (2014) 0.79
Shining the light on Sunshine: a systematic review of the influence of sun exposure on type 2 diabetes mellitus-related outcomes. Clin Endocrinol (Oxf) (2014) 0.79
Serum selenium status in Graves' disease with and without orbitopathy: a case-control study. Clin Endocrinol (Oxf) (2014) 0.79
Ultraviolet index and location are important determinants of vitamin D status in people with human immunodeficiency virus. Photochem Photobiol (2014) 0.79
Vitamin D, muscle function, and falls in older adults: does reduced deposition of intramuscular adipose tissue influence the relationship? J Clin Endocrinol Metab (2013) 0.79
Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment. Clin Interv Aging (2008) 0.78
Population rates of bone densitometry use in Australia, 2001-2005, by sex and rural versus urban location. Med J Aust (2009) 0.78
Social determinants of bone densitometry uptake for osteoporosis risk in patients aged 50yr and older: a systematic review. J Clin Densitom (2012) 0.78
Editorial: inhibin in bone--new tricks for an old dog. J Clin Endocrinol Metab (2006) 0.78
Defective osteoblast function may be responsible for bone loss from the proximal femur despite pamidronate therapy. J Clin Endocrinol Metab (2005) 0.77
Fall and Fracture Risk in Sarcopenia and Dynapenia With and Without Obesity: the Role of Lifestyle Interventions. Curr Osteoporos Rep (2015) 0.77
Associations between socioeconomic status and primary total knee joint replacements performed for osteoarthritis across Australia 2003-10: data from the Australian Orthopaedic Association National Joint Replacement Registry. BMC Musculoskelet Disord (2014) 0.77
What is the missing hormonal factor controlling menopausal bone resorption? J Clin Endocrinol Metab (2010) 0.77
(1)H-NMR analysis of the human urinary metabolome in response to an 18-month multi-component exercise program and calcium-vitamin-D3 supplementation in older men. Appl Physiol Nutr Metab (2014) 0.77
Suburban clustering of vitamin D deficiency in Melbourne, Australia. Asia Pac J Clin Nutr (2008) 0.76
Recruitment and results of a pilot trial of vitamin D supplementation in the general population of Australia. J Clin Endocrinol Metab (2012) 0.76
Vitamin D deficiency is common in HIV-infected southern Australian adults. Antivir Ther (2015) 0.76
Positive effects of intravenous zoledronic acid on bone remodeling and structure: are different effects on osteoblast activity to other oral bisphosphonates responsible? J Bone Miner Res (2008) 0.75
A Single Dose of Prednisolone as a Modulator of Undercarboxylated Osteocalcin and Insulin Sensitivity Post-Exercise in Healthy Young Men: A Study Protocol. JMIR Res Protoc (2016) 0.75
Is high-dose vitamin d harmful? Authors' reply. Calcif Tissue Int (2013) 0.75
Metabolic bone diseases: translational research-preventing fractures with denosumab. Nat Rev Rheumatol (2009) 0.75
The birth of Bone Reports. Bone Rep (2015) 0.75
When continuity of care breaks down: a systems failure in identification of osteoporosis risk in older patients treated for minimal trauma fractures. Med J Aust (2008) 0.75
Myxoedema and a lost wedding ring. Med J Aust (2003) 0.75
Decreased spinal and femoral neck volumetric bone mineral density (BMD) in men with primary osteoporosis and their first-degree male relatives: familial effect on BMD in men. Clin Endocrinol (Oxf) (2007) 0.75
Development of a wearable plantar force measurement device for gait analysis in remote conditions. Conf Proc IEEE Eng Med Biol Soc (2017) 0.75
An elusive phaeochromocytoma. Med J Aust (2011) 0.75